Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze

Psychopharmacology

Volumn 147, Issue 4, 2000, Pages 403-411

  Cole, J C ^a,c   Littleton, J M ^b   Little, H J ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Acamprosate; Anxiety; Conditioning; Ethanol; Naltrexone; Plus maze; Withdrawal

Indexed keywords

ACAMPROSATE; NALTREXONE;

ABSTINENCE; ALCOHOLISM; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONDITIONING; DRUG EFFECT; INCIDENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT;

EID: 0033958458     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050009     Document Type: Article

References (26)

1. Al Qatari M, Bouchenafa O, Littleton JM (1998) Mechanism of action of acamprosate II. Ethanol dependence modifies effect of acamprosate on NMDA receptor binding from membranes from rat cerebral cortex. Alcohol Clin Exp Res 22:810-814
2. Berton F, Francesconi W, Madamba S, Ziegelgansberger W, Siggins GR (1998) Acamprosate enhances NMDA receptor-mediated neurotransmission but inhibits presynaptic GABAB receptors in nucleus accumbens neurones. Alcohol Clin Exp Res 22:183-191
3. Blevins T, Mirshahi T, Chandler LJ, Woodward JJ (1997) Effects of acute and chronic ethanol exposure on heteromeric NMDA receptors expressed in HEK 293 cells. J Neurochem 69:2345-2354
4. Cole JC, Rodgers RJ (1994) Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze: comparison with haloperidol. Psychopharmacology 114:288-296
5. Cole JC, Burroughs GJ, Laverty CR, Seriff NC, Sparham EA, Rodgers RJ (1995) Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha-adrenoceptor mediation. Psychopharmacology 118:425-436
6. Cole JC, Littleton J, Little HJ (1999) Conditioned effects of ethanol in the elevated plus-maze. Psychopharmacology 142:270-279
7. File SE, Andrews N, Wu PY, Zharkovsky A, Zangrossi H (1992) Modification of chlordiazepoxide's behavioural and neurochemical effects by handling and plus-maze experience. Eur J Pharmacol 218:9-14
8. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate limits the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18:125-133
9. Hundt W, Danysz W, Holter SM, Spanagel R (1998) Ethanol and NMDA receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology 135:44-51
10. Kotlinska J, Liljequist S (1996) Oral administration of glycine and polyamine receptor antagonists block ethanol withdrawal seizures. Psychopharmacology 127:238-244
11. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185
12. Littleton J (1995) Acamprosate in alcohol dependence - how does it work? Addiction 90:1179-1188
13. Miller WR (1996) What is a relapse? Fifty ways to leave the wagon. Addiction 91:S15-S28
14. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M (1998) Mechanism of action of acamprosate. Part I. Characterisation of spermidine sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22:802-809
15. Ono T, Nishijo H, Uwano T (1995) Amygdala role in conditioned associative learning. Prog Neurobiol 46:401-422
16. Rodgers RJ, Johnson NJT (1995) Factor analysis of spatiotemporal and ethological measures in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52:297-303
17. Romach MK, Sellers EM (1991) Management of the alcohol withdrawal syndrome. Annu Rev Med 42:323-340
18. Sass H, Soyka M, Mann K, Ziegelgansberger W (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53:673-680
19. Solomon RL (1980) The opponent process theory of acquired motivation; the costs of pleasure and the benefits of pain. Am Psychol 35:691-712
20. Spanagel R, Ziegelgansberger W (1997) Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18:54-59
21. Spanagel R, Holler SM, Allingham K, Landgraf R, Ziegelgansberger W (1996a) Acamprosate and alcohol: I effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:39-44
22. Spanagel R, Pulze J, Stafford A, Schobitz B, Ziegelgansberger W (1996b) Acamprosate and alcohol: II effects on alcohol withdrawal in the rat. Eur J Pharmacol 305:45-50
23. Treil D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463-469
24. Tzschentke TM, Schmidt WJ (1995) NMDA receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett 193:37-40
25. Volpicelli JR, Alterman AI, Hayashida M, O'Brien C (1992) Naltrexone and the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880
26. Zeise ML, Kasparov S, Capogna M, Ziegelgansberger W (1993) Acamprosate decreases postsynaptic potentials in the rat neo-cortex: possible role of excitatory amino acid receptors. Eur J Pharmacol 23:47-52